Finance

Beta
Lists
004720:KRX
PharmGen Science Inc
₩3,195.00
+2.40%
(+75.00) 1D
Jun 12, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 004720...
Open
₩3,125
High
₩3,275
Low
₩3,105
Mkt. cap
72.38B
Avg. vol.
101.58K
Volume
0.00
52-wk high
₩5,490
52-wk low
₩2,940
EPS
-₩5,583
Shares outstanding
22.65M
No. of employees
232
Open
₩3,125
High
₩3,275
Low
₩3,105
Mkt. cap
72.38B
Avg. vol.
101.58K
Volume
0.00
52-wk high
₩5,490
52-wk low
₩2,940
EPS
-₩5,583
Shares outstanding
22.65M
No. of employees
232
News stories
From sources across the web
About PharmGen Science Inc
CEOHee-Deok Park | Hye-Youn Kim
Employees232
Founded1957
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
42.90B
41.65B
44.23B
42.88B
Cost of goods sold
16.00B
14.87B
16.24B
16.18B
Cost of revenue
16.00B
14.87B
16.24B
16.18B
Research and development expenses
1.02B
1.15B
1.15B
1.05B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.35B
22.10B
24.16B
23.00B
Operating expense
24.18B
23.72B
26.15B
24.65B
Total operating expenses
40.18B
38.59B
42.39B
40.83B
Operating income
2.72B
3.06B
1.84B
2.04B
Other non operating income
-912.20M
-6.27B
10.62B
-849.07M
EBT including unusual items
1.98B
-4.55B
996.02M
-665.17M
EBT excluding unusual items
1.98B
-4.55B
4.07B
-665.17M
Income tax expense
926.68M
-632.87M
-2.71B
44.99M
Effective tax rate
46.88%
13.92%
-271.98%
-6.76%
Other operating expenses
73.12M
26.14M
36.23M
42.13M
Net income
1.05B
-3.91B
3.71B
-724.97M
Net profit margin
2.45%
-9.39%
8.38%
-1.69%
Earnings per share
-
-
-
-
Interest and investment income
-
-
100.00M
-
Interest expense
-
-
-4.16B
-
Net interest expenses
-
-
-4.06B
-
Depreciation and amortization charges
302.32M
303.02M
307.39M
305.70M
EBITDA
3.89B
4.22B
2.99B
3.19B
Gain or loss from assets sale
15.09M
-98.00K
1.84M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more